The outcome of unrelieved severe symptomatic aortic stenosis in pregnancy is poor. Though the valve lesion can be corrected surgically before delivery at a low risk to the mother, cardiopulmonary bypass during pregnancy carries a high risk to the fetus. Two patients in the second trimester of pregnancy were successfilly managed with balloon dilatation of the aortic valve. Both delivered healthy infants and were well a year later. Balloon dilatation of the aortic valve is a usefil palliative procedure in the management of pregnant women with severe aortic stenosis. (Br HeartJ 1993;70:544-545) Severe aortic stenosis in patients who become pregnant is an unusual and demanding clinical problem. Altered 
A 26-year-old primigravida presented at 14 weeks' gestation having been referred from her antenatal booking clinic. She had been investigated at the age of 9 and diagnosed as having a bicuspid aortic valve with mild aortic stenosis, but she was subsequently lost to follow up until she became pregnant. During early pregnancy she had complained of mild exertional dyspnoea and had also experienced two episodes of near syncope.
Examination showed a pulse of 90 beats per minute and blood pressure of 90/75 mm Hg. An ejection click was followed by a harsh ejection systolic murmur, audible in the left third intercostal space (4/23) and fetal mortality of 34% (13/48). Termination of pregnancy offered little advantage: two maternal deaths occurred during five attempted therapeutic abortions (mortality 40%), though these abortions were probably undertaken in those patients in whom continuation of the pregnancy was judged to be likely to carry the highest maternal risk.
Improvements in cardiac surgery and anaesthetics have considerably reduced the maternal risk of surgery. The estimated mortality is 1 .5%,2 which is only marginally higher than the risk of cardiopulmonary bypass in a non-pregnant patient. Both valve replacement and surgical valvotomy require cardiopulmonary bypass, which carries a high fetal risk (9.5%).2 In patients in the second trimester of pregnancy these risks to the fetus are unacceptable and alternative management techniques have therefore been explored.
The use of percutaneous techniques in pregnant patients invokes the risks associated with the use of radiation. By using short screening times, lead shielding, and avoiding angiograms the uterine exposure to radiation can be kept to a minimum level. The exposure in our patient of 1-68 mSv is less than the median dose absorbed by a patient after a single abdominal radiograph6 and also below the 2 mSv effective dose limit for an occupationally exposed pregnant individual during nine months of pregnancy. 7 The initial enthusiasm for balloon dilatation in older adults with calcific aortic stenosis has now been tempered by follow up studies showing that the duration of benefit to patients is only about six months and valve replacement is therefore generally recommended.8 Balloon dilatation of the aortic valve was successful in children with aortic stenosis when it was used to provide palliation while they grew,9 thus minimising the number of surgical procedures. The stenosed aortic valves of young adults are similar to those of children and dilatation is often successful. Successful balloon dilatation of the aortic valve during pregnancy has been reported twice before.34
Balloon dilatation of the aortic valve in pregnant patients is a safe and effective way of achieving a successful outcome to pregnancy. If clinically indicated, valve replacement can be undertaken electively postpartum. 
